To maintain treatment of recurrent epithelial ovarian cancer in complete or partial response to platinum-based chemotherapy in adults.
To maintain treatment of fallopian tube cancer in complete or partial response to platinum-based chemotherapy in adults.
To maintain treatment of primary peritoneal cancer in complete or partial response to platinum-based chemotherapy in adults.
To treat advanced ovarian cancer associated with homologous recombination deficiency in adults who have been treated with three or more prior chemotherapy regimens.
To treat advanced fallopian tube cancer associated with homologous recombination deficiency in adults who have been treated with three or more prior chemotherapy regimens.
To treat advanced primary peritoneal cancer associated with homologous recombination deficiency in adults who have been treated with three or more prior chemotherapy regimens.
